ダウンロード数: 208
このアイテムのファイル:
| ファイル | 記述 | サイズ | フォーマット | |
|---|---|---|---|---|
| 33_786.pdf | 493.24 kB | Adobe PDF | 見る/開く |
| タイトル: | 複雑性尿路感染症に対するCefbuperazone(CBPZ)の臨床使用経験 |
| その他のタイトル: | Clinical experience with cefbuperazone in complicated urinary tract infection |
| 著者: | 萬谷, 嘉明  岡本, 知士 氏家, 隆 葉, 剛雄 野呂, 一夫 新里, 滋 横田, 季世士 青木, 光 久保, 隆 大堀, 勉 |
| 著者名の別形: | BANYA, Yoshiaki OKAMOTO, Tomoshi UJIIE, Takashi YOO, Takeo NORO, Kazuo NIISATO, Shigeru YOKOTA, Kiyoshi AOKI, Hikaru KUBO, Takashi OHHORI, Tsutomu |
| キーワード: | Urinary tract infection (UTI) Cefbuperazone (CBPZ) |
| 発行日: | May-1987 |
| 出版者: | 泌尿器科紀要刊行会 |
| 誌名: | 泌尿器科紀要 |
| 巻: | 33 |
| 号: | 5 |
| 開始ページ: | 786 |
| 終了ページ: | 793 |
| 抄録: | Cefbuperazone (CBPZ) was administered to inpatients with complicated urinary tract infections (UTI) at our department. Clinical efficacy and safety were evaluated in 22 chronic cases by the criteria for evaluation of clinical of antimicrobial agents on urinary tract infection. Overall clinical efficacy was excellent in 8 cases, moderate in 9 cases and poor in 5 cases with an effectiveness rate of 77%. Twenty-four of the 34 strains isolated from the patients were eradicated and eradication rate was 71%. Neither subjective nor objective adverse reactions were observed. Abnormal changes in laboratory tests were found in 9 patients, but were probably not related to CBPZ administration. Judging from these results, CBPZ is considered to be an effective and safe antibacterial for the treatment of complicated UTI. |
| URI: | http://hdl.handle.net/2433/119118 |
| PubMed ID: | 3661345 |
| 出現コレクション: | Vol.33 No.5 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。